Preparation method for hydrogenated pyridine derivant and its salt

A technology for hydrogenating pyridine and derivatives, which is applied in the field of medicine and chemical industry, and can solve the problems of many steps, unfavorable industrialized large-scale production, and low yield

Active Publication Date: 2009-01-14
LUNAN PHARMA GROUP CORPORATION
View PDF2 Cites 13 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] EP-192535 bulletin has recorded the preparation method of 2-oxygen-2,4,6,7,7α-hexahydrothieno[3,2-C]pyridinium salt, but this patent method has many synthetic steps and relatively high yield. Low, high synthesis cost, not conducive to large-scale industrial production
[0008] 2-Acetoxy-5-(α-cyclopropylcarbonyl-2-fluorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-C] is described in EP-542411 The method of adding salt to pyridine, but the method disclosed in the patent is difficult to obtain crystals of a single crystal form

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method for hydrogenated pyridine derivant and its salt
  • Preparation method for hydrogenated pyridine derivant and its salt
  • Preparation method for hydrogenated pyridine derivant and its salt

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0037] The preparation of embodiment 1 cyclopropyl-2-fluorobenzyl ketone

[0038]In 100ml of anhydrous tetrahydrofuran solution containing 14.4g (0.6mol) of magnesium strips, add dropwise a mixed solution of 104g (0.55mol) of 2-fluorobenzyl bromide and 400ml of anhydrous tetrahydrofuran while stirring, after the dropwise addition, stir at room temperature 1 hour, then stirred and heated to reflux for 2 hours, the reaction was completed, and after being placed at room temperature, a mixed solution of 37g (0.55mol) cyclopropyl cyanide and 250ml anhydrous tetrahydrofuran was added dropwise with stirring in the reaction system. After 1 hour, heat and reflux and stir the reaction for 2 hours. After the reaction is over, slowly add 300 ml of saturated ammonium chloride aqueous solution dropwise to the reaction system, and then use CH 2 Cl 2 Extraction, the extraction solution was sequentially washed with saturated NaHCO 3 After washing with aqueous solution and saturated brine, dr...

Embodiment 2

[0041] The preparation of embodiment 2α-cyclopropylcarbonyl-2-fluorobenzyl bromide

[0042] Dissolve 68 g (0.38 mol) of cyclopropyl-2-fluorobenzyl ketone obtained in Example 1 in 800 ml of dichloromethane, and add 64 g (0.4 mol) of bromine dropwise under stirring. After the dropwise addition, reflux and stir to react 8 hour, after the reaction was completed, the reaction solution was slowly poured into an ice-water mixture for liquid separation, and the water layer was washed with CH 2 Cl 2 Extraction, combined organic layer, successively with saturated NaHCO 3 aqueous solution and saturated brine, dried over anhydrous sodium sulfate, and the solvent was evaporated under reduced pressure, and the obtained oil was purified by silica gel column chromatography (eluent: petroleum ether: ether = 3:1) to obtain α-cyclopropane 76 g (0.29 mol) of carbonyl-2-fluorobenzyl bromide, yield 77.5%.

[0043] 1 H NMR (CDCI 3 )δppm: 0.91-0.99 (2H, m), 1.00-1.15 (2H, m), 2.11-2.13 (1H, m), ...

Embodiment 3

[0045] The preparation of embodiment 3N-triphenyl-4,5,6,7-tetrahydrothieno[3,2-C]pyridine

[0046] 17.5g (0.1mol) of 4,5,6,7-tetrahydrothieno[3,2-C]pyridine hydrochloride was dissolved in 100ml of dichloromethane, and 4g (0.1mol) of NaOH was added dropwise at room temperature to dissolve in The solution in 50ml of water was added dropwise, then stirred and reacted at room temperature for 2 hours, separated, the organic layer was washed with 1mol / ml dilute hydrochloric acid aqueous solution, and then washed with saturated NaHCO 3 After washing with aqueous solution and saturated brine, dry with anhydrous sodium sulfate for 4 hours, filter, add 14ml of triethylamine, add 27.9g of triphenylchloromethane and 50ml of CH 2 Cl 2 The solution was added dropwise, reacted at room temperature for 6 hours, separated, the organic layer was washed with saturated brine, dried over anhydrous sodium sulfate, and evaporated to dryness under reduced pressure. A viscous liquid was obtained, the...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to hydrogenated pyridine derivates of 2-acetoxy-5-(Alpha-cyclopropyl carbonyl-2-fluorobenzyl)-4, 5, 6, 7-tetrahydrothiophene-[3, 2-C] pyridine as well as a preparation method of salt thereof. The method is to prepare two key intermediates of an Alpha-cyclopropyl carbonyl-2-fluorobenzyl halogen 2 (wherein, X=F, CL, Br and I) and a 2-oxygen-2, 4, 5, 6, 7, 7 Alpha-hexahydrothiophene-[3, 2-C] pyridine salt 3 (wherein, HA=HCL, H2SO4, HBr, HI, etc.), and to obtain the target product by esterifying products acquired through condensing the two key intermediates with acetic anhydride. The target product and the required acid addition salt are added with the needed crystal seed for obtaining crystals with a single crystal form in the process of crystallization.

Description

technical field [0001] The invention belongs to the field of medicine and chemical industry, in particular to hydrogenated pyridine derivatives 2-acetoxy-5-(α-cyclopropylcarbonyl-2-fluorobenzyl)-4,5,6,7-tetrahydrothieno[3 , 2-C] the preparation method of pyridine and salt thereof. Background technique [0002] The hydrogenated pyridine derivative 2-acetoxy-5-(α-cyclopropylcarbonyl-2-fluorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-C]pyridine 1 has the structural formula : [0003] [0004] The salt of hydrogenated pyridine derivative 1 has platelet aggregation inhibitory effect, good oral absorbability, strong metabolic activity and weak toxicity, so it is a promising anticoagulant drug. [0005] The preparation method of hydrogenated pyridine derivative 1 is mainly based on α-cyclopropylcarbonyl-2-fluorobenzyl halide 2 (wherein X=F, CI, B r , I) and 2-oxo-2,4,5,6,7,7α-hexahydrothieno[3,2-C]pyridinium salt 3 (wherein HA=HCl, H 2 SO 4 , HB r , HI, etc.) obtained by condens...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07D495/04A61P7/02
CPCA61K31/4365C07D495/04A61P7/00A61P7/02
Inventor 赵志全白文钦
Owner LUNAN PHARMA GROUP CORPORATION
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products